SCHEMBL1034808

SCHEMBL1034808

O=C(NC1CC1)c1cccc(-c2ccnc(NC3CCCCC3)n2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 2/20 0.55
TTK P33981 2/20 0.55
AURKB Q96GD4 2/20 0.55
INCENP Q9NQS7 2/20 0.55
MAP4K4 O95819 1/20 0.53
RAB9A P51151 4/20 0.51
NPC1 O15118 3/20 0.51
CNR2 P34972 1/20 0.51
HDAC8 Q9BY41 5/20 0.51
HDAC6 Q9UBN7 4/20 0.51
ERN1 O75460 1/20 0.50
ADRA2A P08913 1/20 0.49
ADRA1A P35348 1/20 0.49
HRH1 P35367 1/20 0.49
HTR2B P41595 1/20 0.49
MCHR1 Q99705 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
DGAT1 O75907 1/20 0.48
ROCK2 O75116 1/20 0.48
ROCK1 Q13464 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1030447 0.86 MAPK14 (0.52) AURKATTKAURKBINCENPMAP4K4
SCHEMBL1034911 0.83 ROCK2 (0.57) AURKATTKAURKBINCENPMAP4K4
SCHEMBL1033696 0.83 MTOR (0.61) AURKATTKAURKBINCENPMAP4K4
SCHEMBL1033626 0.81 CDK1 (0.53) AURKATTKAURKBINCENPMAP4K4
SCHEMBL3619159 0.79 ADORA1 (0.59) MAP4K4CNR2HDAC8HDAC6DGAT1
SCHEMBL1030530 0.79 ADORA1 (0.59) MAP4K4CNR2HDAC8HDAC6DGAT1
SCHEMBL1028968 0.79 MAP4K4 (0.55) AURKATTKAURKBINCENPMAP4K4
SCHEMBL1032453 0.78 ABL1 (0.66) AURKATTKAURKBINCENPMAP4K4
SCHEMBL1928387 0.78 RAB9A (0.67) RAB9ANPC1ERN1HTR2BL3MBTL1
SCHEMBL1031156 0.77 ALDH1A1 (0.53) AURKATTKAURKBINCENPMAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO claimed
WO-2011008931-A2 ARYLPYRIMIDINE COMPOUNDS AND COMBINATION THERAPY COMPRISING SAME FOR TREATING CYSTIC FIBROSIS & RELATED DISORDERS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2011-01-20 WO disclosed
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO disclosed